Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2013; 138(25/26): 1365-1368
DOI: 10.1055/s-0033-1343223
DOI: 10.1055/s-0033-1343223
Übersicht | Review article
Rheumatologie,
Immunologie
Versorgung von Patienten mit Morbus Behçet
Medical care of patients with Behçet’s diseaseFurther Information
Publication History
10 December 2012
26 March 2013
Publication Date:
12 June 2013 (online)
-
Literatur
- 1 Alpsoy E, Akman A. Behçet’s disease: an algorithmic approach to its treatment. Arch Dermatol Res 2009; 301: 693-702
- 2 Altenburg A, Mahr A, Maldini C et al. Epidemiologie und Klinik des Morbus Adamatiades-Behçet in Deutschland. Aktuelle Daten. Ophthalmologe 2012; 109: 531-541
- 3 Altenburg A, Micheli CK, Maldini C et al. Klinik und Therapie chronisch rezidivierender Aphthen. Hautarzt 2012; 63: 693-703
- 4 Altenburg A, Papoutsis N, Orawa H et al. Morbus Adamantiades-Behçet: Epidemiologie, pathogenetische Konzepte und therapeutische Möglichkeiten. Akt Dermatol 2006; 32: 360-364
- 5 Borhani Haghighli A. Treatment of neuro-Behçet’s disease: an update. Expert Rev Neurother 2009; 9: 565-574
- 6 Borhani Haghighi A, Safari A. Proposing an algorithm for treatment of different manifestations of neuro-Behçet’s disease. Clin Rheumatol 2010; 29: 683-686
- 7 Ciancio G, Colina M, La Corte R et al. Nicotine-patch therapy on mucocutaneous lesions of Behçet’s disease: a case series. Rheumatology 2010; 49: 501-504
- 8 Davatchi F. Diagnosis/Classification Criteria for Behçet’s Disease. Hindawi Publishing Corporation Pathology Research International Volume 2012; Article ID 607921, doi:
- 9 Demary W. Die Rolle von Vitamin D bei entzündlichen Erkrankungen. Akt Rheumatol 2012; 37: 220-227
- 10 Deuter CME, Zierhut M, Möhle A et al. Long-Term Remission After Cessation of Interferon-α Treatment in Patients With Severe Uveitis Due to Behçet's Disease. Arthritis & Rheumatism 2010; 62: 2796-2805
- 11 Dührsen U, Kirch W. Diagnostik des Behçet-Syndroms. Dtsch Med Wochenschr 1985; 110: 264-267
- 12 Dührsen U, Kirch W. Therapie des Behçet-Syndroms. Dtsch Med Wochenschr 1985; 110: 267-270
- 13 Eichhorn A, Siepmann M, Kirch W. Medikamentöse Versorgung des Behçet-Syndroms mit Chlorambucil. Eine retrospektive Betrachtung zweier Fälle. Med Klin 2010; 105: 20-25
- 14 Hello M, Barbarot S, Bastuji-Garin S et al. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis. Medicine 2010; 89: 176-182
- 15 Karaty S, Yildirim K, Karakuzu A et al. Vitamin D status in patients with Behçet’s Disease. Clinics 2011; 66: 721-723
- 16 Köse O. Development of Immunopathogenesis Strategies to Treat Behçet’s Disease. Hindawi Publishing Corporation Pathology Research International Volume 2012; Article ID 261989, doi:
- 17 Kötter I. EULAR-Empfehlungen für die Behandlung des Morbus Behçet. Bericht einer Task Force des European Standing Committee for International Clinical Studies Including Therapeutics (ESCIST). Z Rheumatol 2009; 68: 157-161
- 18 Kötter I, Xenitidis T, Fierlbeck G et al. Extraokuläre Manifestationen des Morbus Behçet. Ophthalmologe 2012; 109: 548-557
- 19 Kump LI, Moeller KL et al. Behçet’s Disease- Comparing Three Decades of Treatment Response at the National Eye Institute. Can J Opththalmol 2008; 43: 468-472
- 20 Matsumura K, Nakase H, Chiba T. Efficacy of Oral Tacrolimus on Intestinal Behçet’s Disease. Inflamm Bowel Dis 2010; 16: 188-189
- 21 Melikoglu MA, Melikoglu M. The relationship between disease activity and depression in patients with Behçet disease and rheumatoid arthritis. Rheumatol Int 2010; 30: 941-946
- 22 Monastirli A, Chroni E, Georgiou S et al. Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet’s disease. Q J Med 2010; 103: 787-790
- 23 Palopoli J, Waxman J. Recurrent Apthous Stomatitis and Vitamin B12 Deficiency. South Med J 1990; 83: 475-477
- 24 Pipitone N, Olivieri I, Padula A et al. Infliximab for the Treatment of Neuro-Behçet’s Disease: A Case Series and Review of the Literature. Arthritis & Rheumatism 2008; 59: 285-290
- 25 Pleyer U, Mackensen F, Winterhalter S et al. Anti-TNF-Therapie bei Uveitis. Eine Standortbestimmung. Ophthalmologe 2011; 108: 13-20
- 26 Siepmann M, Kirch W. Sensory symptoms in Behçet's syndrome. Adv Exp Med Biol 2003; 528; 383-384
- 27 Störk S, Kneitz C, Bröcker EB et al. Morbus Adamantiades-Behçet. Eine klinische Übersicht. Med Klin 2008; 103: 143-152
- 28 Zaghetto JM, Yamamoto MM, Souza MB et al. Chlorambucil and cyclosporine A in Brazilian patients with Behçet’s uveitis – A retrospective study. Arq Bras Oftalmol 2010; 73: 40-46